Technical Analysis for XBI - SPDR S&P Biotech ETF
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 83.49 | 1.54% | 1.27 |
XBI closed up 1.54 percent on Friday, April 26, 2024, on 89 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Crossed Above 200 DMA | Bullish | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Fell Below 200 DMA | Bearish | 1.54% | |
| Gapped Down | Weakness | 1.54% | |
| Shooting Star Candlestick | Bearish | -1.42% | |
| Gapped Up | Strength | -1.42% | |
| Oversold Stochastic | Weakness | -1.42% | |
| New Downtrend | Bearish | -0.31% |
| Alert | Time |
|---|---|
| Up 2% | about 19 hours ago |
| 60 Minute Opening Range Breakout | about 21 hours ago |
| 200 DMA Resistance | about 21 hours ago |
| Rose Above Previous Day's High | about 23 hours ago |
| Rose Above 200 DMA | about 23 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index.
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
Keywords: Index Fund Stock Market Index Biotechnology S&P Total Market Index ( Biotechnology Segment
Classification
Keywords: Index Fund Stock Market Index Biotechnology S&P Total Market Index ( Biotechnology Segment
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 103.52 |
| 52 Week Low | 63.7897 |
| Average Volume | 11,594,311 |
| 200-Day Moving Average | 82.68 |
| 50-Day Moving Average | 92.66 |
| 20-Day Moving Average | 87.38 |
| 10-Day Moving Average | 84.10 |
| Average True Range | 2.37 |
| RSI (14) | 35.90 |
| ADX | 28.72 |
| +DI | 17.37 |
| -DI | 35.37 |
| Chandelier Exit (Long, 3 ATRs) | 88.78 |
| Chandelier Exit (Short, 3 ATRs) | 88.26 |
| Upper Bollinger Bands | 94.45 |
| Lower Bollinger Band | 80.32 |
| Percent B (%b) | 0.22 |
| BandWidth | 16.17 |
| MACD Line | -2.76 |
| MACD Signal Line | -2.46 |
| MACD Histogram | -0.2997 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 86.84 | ||||
| Resistance 3 (R3) | 86.59 | 85.23 | 86.28 | ||
| Resistance 2 (R2) | 85.23 | 84.38 | 85.35 | 86.09 | |
| Resistance 1 (R1) | 84.36 | 83.85 | 84.80 | 84.61 | 85.91 |
| Pivot Point | 83.00 | 83.00 | 83.22 | 83.12 | 83.00 |
| Support 1 (S1) | 82.13 | 82.15 | 82.57 | 82.38 | 81.07 |
| Support 2 (S2) | 80.77 | 81.62 | 80.89 | 80.89 | |
| Support 3 (S3) | 79.90 | 80.77 | 80.70 | ||
| Support 4 (S4) | 80.15 |
